Point-Of-Care Testing (POCT) Market In US 2026-2030

Description

The point-of-care testing (POCT) market in us is forecasted to grow by USD 12352.3 mn during 2025-2030, accelerating at a CAGR of 9.6% during the forecast period. The report on the point-of-care testing (POCT) market in us provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising burden of chronic diseases, integration of digital telehealth platforms, decentralization of healthcare delivery models.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Market Scope
Base Year	2025
End Year	2030
Series Year	2026-2030
Growth Momentum	Accelerate
YOY 2026	9.1%
CAGR	9.6%
Incremental Value	$12352.3 mn

Technavio's point-of-care testing (POCT) market in us is segmented as below:

By Type

OTC testing
Prescription-based testing

By Application

Blood glucose testing
Infectious diseases testing
Cardiac markers testing
Pregnancy and fertility testing
Others

By Product Type

Immunoassays
Clinical chemistry assays
Nucleic acid amplification testing
Hematology
Cell-based assays

Geography

North America
- US

This study identifies the decentralization of diagnostic testing services as one of the prime reasons driving the point-of-care testing (POCT) market in us growth during the next few years. Also, growth of wearable diagnostic integration and expansion of rapid molecular diagnostics will lead to sizable demand in the market.

The report on the point-of-care testing (POCT) market in us covers the following areas:

Point-of-care testing (POCT) market in us sizing
Point-of-care testing (POCT) market in us forecast
Point-of-care testing (POCT) market in us industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading point-of-care testing (POCT) market in us vendors that include Abbott Laboratories, ACON Laboratories Inc., Beckman Coulter Inc., Becton Dickinson and Co., Binx Health Inc., BioMerieux SA, Cepheid Inc., Chembio Diagnostics Inc., Danaher Corp., EKF Diagnostics Holdings Plc, F. Hoffmann La Roche Ltd., Nova Biomedical Corp., OPTI Medical Systems Inc., OraSure Technologies Inc., PTS Diagnostics, QuidelOrtho Corp., Sekisui Diagnostics LLC, Siemens Healthineers AG, Trinity Biotech Plc, Werfenlife SA. Also, the point-of-care testing (POCT) market in us analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR75991

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Country Market Characteristics
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by Product Type
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030

3 Market Landscape

3.1 Market ecosystem
3.2 Market characteristics
3.3 Value chain analysis

4 Market Sizing

4.1 Market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2025
4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

5.1 Point-Of-Care Testing (POCT) Market in US 2020 - 2024
- Historic Market Size - Data Table on Point-Of-Care Testing (POCT) Market in US 2020 - 2024 ($ million)
5.2 Type segment analysis 2020 - 2024
- Historic Market Size - Type Segment 2020 - 2024 ($ million)
5.3 Application segment analysis 2020 - 2024
- Historic Market Size - Application Segment 2020 - 2024 ($ million)
5.4 Product Type segment analysis 2020 - 2024
- Historic Market Size - Product Type Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

6.1 Impact of AI on Point-of-Care Testing (POCT) Market in US
6.2 Impact of geopolitical conflicts on Point-of-Care Testing (POCT) Market in US

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
7.7 Market condition

8 Market Segmentation by Type

8.1 Market segments
8.2 Comparison by Type
8.3 OTC testing - Market size and forecast 2025-2030
8.4 Prescription-based testing - Market size and forecast 2025-2030
8.5 Market opportunity by Type
- Market opportunity by Type ($ million)

9 Market Segmentation by Application

9.1 Market segments
9.2 Comparison by Application
9.3 Blood glucose testing - Market size and forecast 2025-2030
9.4 Infectious diseases testing - Market size and forecast 2025-2030
9.5 Cardiac markers testing - Market size and forecast 2025-2030
9.6 Pregnancy and fertility testing - Market size and forecast 2025-2030
9.7 Others - Market size and forecast 2025-2030
9.8 Market opportunity by Application
- Market opportunity by Application ($ million)

10 Market Segmentation by Product Type

10.1 Market segments
10.2 Comparison by Product Type
10.3 Immunoassays - Market size and forecast 2025-2030
10.4 Clinical chemistry assays - Market size and forecast 2025-2030
10.5 Nucleic acid amplification testing - Market size and forecast 2025-2030
10.6 Hematology - Market size and forecast 2025-2030
10.7 Cell-based assays - Market size and forecast 2025-2030
10.8 Market opportunity by Product Type
- Market opportunity by Product Type ($ million)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Drivers, Challenges, and Opportunity

12.1 Market drivers
- Rising burden of chronic diseases
- Integration of digital telehealth platforms
- Decentralization of healthcare delivery models
12.2 Market challenges
- Complex regulatory hurdles and compliance
- Reimbursement instability and revenue pressures
- Technological integration and connectivity gaps
12.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
12.4 Market opportunities
- Decentralization of diagnostic testing services
- Growth of wearable diagnostic integration
- Expansion of rapid molecular diagnostics

13 Competitive Landscape

13.1 Overview
13.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
13.3 Landscape disruption
- Overview on factors of disruption
13.4 Industry risks
- Impact of key risks on business

14 Competitive Analysis

14.1 Companies profiled
- Companies covered
14.2 Company ranking index
- Company ranking index
14.3 Market positioning of companies
- Matrix on companies position and classification
14.4 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- SWOT
14.5 Beckman Coulter Inc.
- Beckman Coulter Inc. - Overview
- Beckman Coulter Inc. - Product / Service
- Beckman Coulter Inc. - Key offerings
- SWOT
14.6 Becton Dickinson and Co.
- Becton Dickinson and Co. - Overview
- Becton Dickinson and Co. - Business segments
- Becton Dickinson and Co. - Key news
- Becton Dickinson and Co. - Key offerings
- Becton Dickinson and Co. - Segment focus
- SWOT
14.7 BioMerieux SA
- BioMerieux SA - Overview
- BioMerieux SA - Business segments
- BioMerieux SA - Key offerings
- BioMerieux SA - Segment focus
- SWOT
14.8 Cepheid Inc.
- Cepheid Inc. - Overview
- Cepheid Inc. - Product / Service
- Cepheid Inc. - Key offerings
- SWOT
14.9 Danaher Corp.
- Danaher Corp. - Overview
- Danaher Corp. - Business segments
- Danaher Corp. - Key news
- Danaher Corp. - Key offerings
- Danaher Corp. - Segment focus
- SWOT
14.10 EKF Diagnostics Holdings Plc
- EKF Diagnostics Holdings Plc - Overview
- EKF Diagnostics Holdings Plc - Business segments
- EKF Diagnostics Holdings Plc - Key offerings
- EKF Diagnostics Holdings Plc - Segment focus
- SWOT
14.11 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
14.12 Nova Biomedical Corp.
- Nova Biomedical Corp. - Overview
- Nova Biomedical Corp. - Product / Service
- Nova Biomedical Corp. - Key offerings
- SWOT
14.13 OraSure Technologies Inc.
- OraSure Technologies Inc. - Overview
- OraSure Technologies Inc. - Business segments
- OraSure Technologies Inc. - Key offerings
- OraSure Technologies Inc. - Segment focus
- SWOT
14.14 PTS Diagnostics
- PTS Diagnostics - Overview
- PTS Diagnostics - Product / Service
- PTS Diagnostics - Key offerings
- SWOT
14.15 QuidelOrtho Corp.
- QuidelOrtho Corp. - Overview
- QuidelOrtho Corp. - Business segments
- QuidelOrtho Corp. - Key offerings
- QuidelOrtho Corp. - Segment focus
- SWOT
14.16 Sekisui Diagnostics LLC
- Sekisui Diagnostics LLC - Overview
- Sekisui Diagnostics LLC - Product / Service
- Sekisui Diagnostics LLC - Key offerings
- SWOT
14.17 Siemens Healthineers AG
- Siemens Healthineers AG - Overview
- Siemens Healthineers AG - Business segments
- Siemens Healthineers AG - Key offerings
- Siemens Healthineers AG - Segment focus
- SWOT
14.18 Trinity Biotech Plc
- Trinity Biotech Plc - Overview
- Trinity Biotech Plc - Product / Service
- Trinity Biotech Plc - Key offerings
- SWOT

15 Appendix

15.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
15.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
15.3 Currency conversion rates for US$
- Currency conversion rates for US$
15.4 Research methodology
- Research methodology
15.5 Data procurement
- Information sources
15.6 Data validation
- Data validation
15.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
15.8 Data synthesis
- Data synthesis
15.9 360 degree market analysis
- 360 degree market analysis
15.10 List of abbreviations
- List of abbreviations